Dyzantil 300mg modified-release tablets
BNF presentation 0408010W0BKABA1 within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0408010W0BKABA1
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
275
NHS spend (£)
£2,252.60
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 55 |
| December 2024 | 14 |
| November 2024 | 53 |
| October 2024 | 68 |
| September 2024 | 2 |
| August 2024 | 5 |
| July 2024 | 60 |
| May 2024 | 17 |
| June 2021 | 1 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 21 | No data available |
|
Creffield Medical Group
ODS F81115
|
19 | 06T - SUFFOLK AND NORTH EAST ESSEX ICB |
| Unknown pharmacy | 17 | No data available |
| Unknown pharmacy | 16 | No data available |
| Unknown pharmacy | 12 | No data available |
|
New Barn Close Surgery
ODS M81029
|
10 | 18C - HEREFORDSHIRE & WORCESTERSHIRE ICB |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |